Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04138381
Brief Title: Selinexor as a Single Agent and in Combination With Imatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors. (SeliGIST)

First Submitted : September 16, 2019
First Submitted that Met QC Criteria : October 22, 2019
First Posted : October 24, 2019

Last Update Submitted that Met QC Criteria : October 21, 2020
Last Update Posted : October 23, 2020